{"id":"W4205563331","doi":"10.2165/00128413-200514820-00086","title":"Health Canada has approved Pfizer's dalteparin sodium [Fragmin],","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine; Pharmacology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008873872,0.0005656001,0.0005732882,0.000789717,0.00131851,0.0009847544,0.001148917,0.003045308,0.03076116],"category_scores_gemma":[0.002543343,0.0002486415,0.0006308281,0.0004969041,0.0009159091,0.0003691333,0.0004438461,0.002110678,0.005787936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003423506,"about_ca_system_score_gemma":0.01018865,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.08719347,"about_ca_topic_score_gemma":0.2259559,"domain_scores_codex":[0.9993367,0.00009234448,0.00002452784,0.00007325596,0.000343211,0.00012998],"domain_scores_gemma":[0.9987393,0.0002511103,0.0001201288,0.00004735867,0.0003887058,0.000453447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003553582,0.0007662236,0.002972153,0.0006620453,0.00006782201,0.001399301,0.00009173361,0.0002385603,0.02210949,0.005421106,0.5193405,0.4433776],"study_design_scores_gemma":[0.0015358,0.001978117,0.006017169,0.000194968,0.0001259685,0.00221194,0.00008244449,0.0004519496,0.0132444,0.0006369064,0.973474,0.00004647504],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.1010617,0.1281249,0.01145195,0.2209002,0.01652597,0.001934111,0.01211676,0.00996872,0.4979157],"genre_scores_gemma":[0.4323255,0.03773557,0.01891673,0.06807958,0.003113343,0.0003195851,0.008365926,0.0006274107,0.4305164],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.9128065,"threshold_uncertainty_score":0.1733719,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.131651619425894,"score_gpt":0.4079476999646185,"score_spread":0.2762960805387245,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}